Similarly, the expression levels of VEGF were found associated with decreased activation of CD8+ T and TH1 cell response on colorectal tumors (13), and the VEGF-enhanced expression of inhibitory checkpoints on CD8+ T cells can be reverted by VEGF- and VEGFR-targeted agents (14). This evidence concerns the gene VEGFA and colorectal neoplasm.